Application no. and date | 21154665.0 (espacenet) (Federated) (European Patent Register), 20130524 | Patent/reg. no. and date | DK/EP 3851107, 20221019 | Publication date | 20210721 | Priority no. and date | US 201261651669 P, 20120525, US 201261691083 P, 20120820, US 201261715907 P, 20121019, US 201361759520 P, 20130201, US 201361781629 P, 20130314 | EP pub. no. and date |
EP 3851107 20210721 | Effective date | | Applicant/owner | Corcept Therapeutics Incorporated, 149 Commonwealth Drive
Menlo Park, CA 94025, US | Applicant ref. no. | V451173DK00 | Inventor | JOHNSON, Tony, 8/9 Spire Green Centre Flex Meadow
Harlow, Essex, GB, RAY, Nicholas, 8/9 Spire Green Centre Flex Meadow
Harlow, Essex, GB, WALTERS, Iain, BioCity Pennyfoot Street
Nottingham, Nottinghamshire, GB, HUNT, Hazel, Edenderry House Bracken Close
Storrington West, Sussex, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61P 25/24 (2006.01) , C07D 471/04 (2006.01) | Title | Heteroaryl-ketonkondenseret azadecalin som glucocorticoidreceptormodulatorer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|